J B Chemicals & Pharmaceuticals Ltd Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Cr

Consolidate Annual Results

Mar'26

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Net Sales

4,147.79

3,917.99

3,484.18

3,149.28

2,424.24

2,042.52

1,774.73

Other Operating Income

0.00

Total Operating income

4,147.79

3,917.99

3,484.18

3,149.28

2,424.24

2,042.52

1,774.73

Raw Material Cost

912.44

820.03

816.28

783.98

602.22

542.39

452.48

Purchase of Finished goods

477.90

496.95

412.62

395.22

258.17

200.37

182.31

(Increase) / Decrease In Stocks

-94.07

-0.43

-46.85

-11.00

-17.45

-41.26

-3.99

Employee Cost

772.70

687.61

601.41

543.45

439.24

340.60

322.92

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

971.39

881.99

803.83

741.88

598.61

440.01

443.44

Total Expenditure (Excl Depreciation)

3,040.36

2,886.15

2,587.29

2,453.53

1,880.79

1,482.11

1,397.16

Operating Profit (PBDIT) excl Other Income

1,107.43

1,031.84

896.89

695.75

543.45

560.41

377.57

Other Income

60.15

38.32

37.27

9.94

39.23

112.38

50.67

Operating Profit (PBDIT)

1,167.58

1,070.16

934.16

705.69

582.68

672.79

428.24

Interest

5.57

11.73

44.33

36.05

5.12

7.24

3.03

Exceptional Items

-27.18

0.00

-10.00

Gross Profit (PBDT)

1,134.83

1,058.43

889.83

669.64

577.56

665.55

415.21

Depreciation

182.50

171.04

138.32

114.41

72.66

68.67

66.32

Profit Before Tax

952.33

887.39

751.51

555.23

504.90

596.89

348.89

Tax

242.86

227.81

198.88

145.23

118.86

148.36

76.50

Provisions and contingencies

0.00

Profit After Tax

709.47

659.58

552.63

410.00

386.04

448.52

272.39

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

709.47

659.58

552.63

410.00

386.04

448.52

272.39

Share in Profit of Associates

0.00

Minority Interest

0.00

-0.17

-0.68

-0.56

-0.35

Other related items

0.00

Consolidated Net Profit

709.47

659.58

552.63

409.83

385.36

447.96

272.05

Equity Capital

16.06

15.57

15.52

15.48

15.46

Face Value

1.0

2.0

Reserves

4,143.16

3,417.75

2,907.81

2,464.87

2,118.67

1,794.27

1,420.03

Earnings per share (EPS)

44.18

42.36

35.61

26.47

24.93

57.95

35.19

Diluted Earnings per share

44.45

41.56

34.85

52.34

49.86

57.96

34.2

Operating Profit Margin (Excl OI)

26.7%

26.34%

25.74%

22.09%

22.42%

27.44%

21.27%

Gross Profit Margin

27.36%

27.01%

25.54%

21.26%

23.82%

32.58%

23.4%

PAT Margin

17.1%

16.83%

15.86%

13.02%

15.92%

21.96%

15.35%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Mar 2026 is 5.87% vs 12.45% in Mar 2025

Consolidate Net Profit

YoY Growth in year ended Mar 2026 is 7.56% vs 19.35% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 7.33% vs 15.05% in Mar 2025

Interest

YoY Growth in year ended Mar 2026 is -52.51% vs -73.54% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of J B Chemicals & With

Select Peers

Figures in Cr

Consolidate Annual Results

Change(INR)

Change(%)

Net Sales

4,147.79

8,939.59

-4,791.80

-53.60%

Other Operating Income

0.00

Total Operating income

4,147.79

8,939.59

-4,791.80

-53.60%

Raw Material Cost

912.44

2,276.82

-1,364.38

-59.92%

Purchase of Finished goods

477.90

547.78

-69.88

-12.76%

(Increase) / Decrease In Stocks

-94.07

-46.05

-48.02

-104.28%

Employee Cost

772.70

1,983.99

-1,211.29

-61.05%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

971.39

2,450.91

-1,479.52

-60.37%

Total Expenditure (Excl Depreciation)

3,040.36

7,213.45

-4,173.09

-57.85%

Operating Profit (PBDIT) excl Other Income

1,107.43

1,726.14

-618.71

-35.84%

Other Income

60.15

92.80

-32.65

-35.18%

Operating Profit (PBDIT)

1,167.58

1,818.94

-651.36

-35.81%

Interest

5.57

84.93

-79.36

-93.44%

Exceptional Items

-27.18

-205.05

177.87

86.74%

Gross Profit (PBDT)

1,134.83

1,528.96

-394.13

-25.78%

Depreciation

182.50

397.82

-215.32

-54.12%

Profit Before Tax

952.33

1,131.14

-178.81

-15.81%

Tax

242.86

343.61

-100.75

-29.32%

Provisions and contingencies

0.00

Profit After Tax

709.47

787.53

-78.06

-9.91%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

709.47

787.53

-78.06

-9.91%

Share in Profit of Associates

0.00

-2.29

2.29

100.00%

Minority Interest

0.00

-47.56

47.56

100.00%

Other related items

0.00

Consolidated Net Profit

709.47

737.68

-28.21

-3.82%

Equity Capital

16.06

25.37

-9.31

-36.70%

Face Value

1.00

0.00

Reserves

4,143.16

6,923.08

-2,779.92

-40.15%

Earnings per share (EPS)

44.18

29.08

15.10

51.93%

Diluted Earnings per share

44.45

29.08

15.37

52.85%

Operating Profit Margin (Excl OI)

26.70%

19.31%

0.00

7.39%

Gross Profit Margin

27.36%

17.10%

0.00

10.26%

PAT Margin

17.10%

8.81%

0.00

8.29%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Annual - Net Sales

Net Sales 4,147.79 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 5.87% vs 12.45% in Mar 2025

Annual - Consolidate Net Profit

Consolidate Net Profit 709.47 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 7.56% vs 19.35% in Mar 2025

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 1,107.43 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is 7.33% vs 15.05% in Mar 2025

Annual - Interest

Interest 5.57 Cr

in Mar 2026

Figures in Cr

YoY Growth in year ended Mar 2026 is -52.51% vs -73.54% in Mar 2025

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 26.70%

in Mar 2026

Figures in %

YoY Growth in year ended Mar 2026 has improved from Mar 2025